Japan Ophthalmic Viscoelastic Devices Market Overview
As per MRFR analysis, the Japan Ophthalmic Viscoelastic Devices Market Size was estimated at 178.75 (USD Million) in 2023. The Japan Ophthalmic Viscoelastic Devices Market Industry is expected to grow from 191.88(USD Million) in 2024 to 734 (USD Million) by 2035. The Japan Ophthalmic Viscoelastic Devices Market CAGR (growth rate) is expected to be around 12.972% during the forecast period (2025 - 2035).
Key Japan Ophthalmic Viscoelastic Devices Market Trends Highlighted
The Japan Ophthalmic Viscoelastic Devices Market is shaped by several vital market drivers that influence its growth trajectory. The aging population in Japan significantly impacts the demand for ophthalmic procedures as age-related eye conditions like cataracts and glaucoma become more prevalent.
This demographic trend creates a sustained need for viscoelastic devices during surgeries such as cataract extractions and intraocular lens implantations. Furthermore, advancements in technology lead to the development of innovative viscoelastic products that enhance surgical outcomes and increase safety, thereby driving market growth.
Opportunities to be explored within this market include the potential for collaboration between Japanese manufacturers and international companies to leverage expertise and broaden product offerings.Further shifts in eco-friendly practices focus on creating biodegradable viscoelastic devices, paying attention to rising environmental awareness in Japan. Moreover, additional funding in research and development could provide unique solutions for unmet clinical challenges and improve the efficiency of surgical procedures.
Recently, there has been a significant trend toward minimally invasive surgical procedures in the field of ophthalmology in Japan. Both doctors as well as patients are increasingly opting for viscoelastic devices that enable faster recovery and fewer complications, thereby decreasing the overall recovery time. There is also a higher increasing trend with respect to awareness about eye care, encouraging more people to undergo routine examinations and treatments that, in turn, increase the need for ophthalmic devices.
As technology evolves, the integration of digital solutions, such as telemedicine for follow-ups, is also gaining traction in the Japanese healthcare landscape, further shaping the market dynamics for ophthalmic viscoelastic devices.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Japan Ophthalmic Viscoelastic Devices Market Drivers
Increasing Aging Population in Japan
Japan has one of the most rapidly aging populations in the world, which significantly drives the Japan Ophthalmic Viscoelastic Devices Market Industry. According to the Ministry of Internal Affairs and Communications in Japan, by 2025, it is expected that 29.1% of the population will be 65 years or older.
This increase contributes to a higher prevalence of age-related eye diseases such as cataracts and glaucoma, which require surgical interventions utilizing ophthalmic viscoelastic devices.
Furthermore, the Japan National Institute of Population and Social Security Research reports that the number of people aged 75 years and over has already reached approximately 17 million, with projections indicating that this figure may rise to 25 million by 2040. Such demographic shifts necessitate advanced surgical procedures, thereby directly leading to greater demand for ophthalmic viscoelastic devices in Japan.
Technological Advancements in Surgical Procedures
The Japan Ophthalmic Viscoelastic Devices Market Industry is witnessing accelerated growth due to significant advancements in surgical techniques and devices. Innovations such as femtosecond laser-assisted cataract surgery and minimally invasive surgical techniques are raising the safety and effectiveness of procedures.
According to a report from the Japan Society of Ophthalmology, the adoption of these technologies has led to improved surgical outcomes, with studies indicating a 20% reduction in complication rates in cataract surgeries.Major players like Alcon and Bausch + Lomb are investing heavily in Research and Development to improve their viscoelastic device offerings, leading to wider acceptance in surgical practices and facilitating market growth.
Rising Prevalence of Eye Disorders
The prevalence of eye disorders in Japan is on the rise, particularly due to lifestyle changes and a lack of regular eye check-ups. The World Health Organization estimates that around 5.89 million people in Japan suffer from severe visual impairment, a statistic that emphasizes the urgent need for surgical solutions.
Additionally, the Ministry of Health, Labour and Welfare has reported an increasing diagnosis rate for eye disorders, with incidences of diabetic retinopathy and age-related macular degeneration growing by approximately 10% over the last decade.The increasing number of surgeries to correct these conditions directly boosts the demand for ophthalmic viscoelastic devices, positioning this market for even more robust growth in the coming years.
Government Initiatives and Healthcare Reforms
Government policies aimed at improving healthcare accessibility in Japan are also propelling the Japan Ophthalmic Viscoelastic Devices Market Industry forward. The Japanese government has implemented various healthcare reforms to enhance the quality and accessibility of medical services, particularly for elderly patients.
The establishment of the Healthcare and Medical Strategy Headquarters has led to increased funding for advanced medical technologies and surgical treatments.According to the Ministry of Health, Labour and Welfare, the government plans to invest an additional 1.8 trillion Yen in medical technology by 2025, which is expected to enhance the procurement of innovative surgical materials, including ophthalmic viscoelastic devices. These initiatives underscore the supportive policy environment that fosters growth in this market.
Japan Ophthalmic Viscoelastic Devices Market Segment Insights
Ophthalmic Viscoelastic Devices Market Type Insights
The Japan Ophthalmic Viscoelastic Devices Market is segmented into various types, notably including Cohesive OVDs and Dispersive OVDs. The market is expected to showcase robust growth, driven by an increasing number of ophthalmic surgical procedures prompted by a rising prevalence of eye disorders within the population. The Cohesive OVDs segment is particularly significant, as these devices effectively maintain anterior chamber stability and aid in the protection of the corneal endothelium during surgery.
This characteristic is vital in procedures such as cataract surgery, where maintaining clear access and visibility is paramount for optimal outcomes.In contrast, Dispersive OVDs serve a different yet essential role, often preferred for their ability to coat intraocular surfaces and minimize postoperative inflammation.
As the aging population in Japan continues to expand, the demand for various surgical interventions will likely increase, propelling the need for advanced ophthalmic viscoelastic devices. Additionally, innovations in product design and formulations are anticipated to enhance patient outcomes and surgical efficiency, further contributing to the significance of these segments within the broader Japan Ophthalmic Viscoelastic Devices Market.
The interplay between technological advancements and the growing healthcare infrastructure in Japan is expected to create a conducive environment for the expansion of both Cohesive and Dispersive OVDs, thereby influencing overall market growth.
The increasing emphasis on minimally invasive surgical techniques in ophthalmology also underscores the relevance of these types, as they are integral to improving surgical precision and patient recovery times. Overall, both types of ophthalmic viscoelastic devices play a pivotal role in enhancing surgical practices and improving patient comfort, signifying their indispensable presence in Japan's evolving ophthalmic sector.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Ophthalmic Viscoelastic Devices Market Application Insights
The Application segment of the Japan Ophthalmic Viscoelastic Devices Market encompasses critical procedures such as Cataract Surgery, Glaucoma Surgery, Corneal Transplantation, and Vitreoretinal Surgery. With the aging population in Japan, the demand for Cataract Surgery is notably significant, as cataracts remain a primary cause of visual impairment.
Likewise, Glaucoma Surgery is on the rise due to an increase in glaucoma incidences, further underscoring the necessity of effective devices to maintain eye pressure. Corneal Transplantation is vital in restoring vision in patients with corneal diseases, making advanced viscoelastic devices essential for success during surgery.
Vitreoretinal Surgery addresses various retinal disorders, where the safety and efficacy of viscoelastic devices can play a pivotal role. Collectively, these applications contribute to enhanced surgical outcomes and patient satisfaction in Japan, driven by technological advancements and increasing healthcare accessibility.
The continuous evolution of surgical techniques and the rising prevalence of eye conditions in the aging demographic positions this segment as a significant growth area within the Japan Ophthalmic Viscoelastic Devices Market.Furthermore, ongoing Research and Development efforts in this field promise to yield innovative solutions, thus meeting the diverse needs of ophthalmic procedures.
Ophthalmic Viscoelastic Devices Market End User Insights
The End User segment of the Japan Ophthalmic Viscoelastic Devices Market presents a diverse landscape shaped by the needs of various facilities, primarily including Ophthalmic Clinics and Phaco Centers, Hospitals, as well as Academic and Research Institutes.
Ophthalmic Clinics and Phaco Centers hold a crucial role in the delivery of specialized eye care services, particularly in cataract surgeries where viscoelastic devices are integral to maintaining anterior chamber stability. Hospitals account for a substantial portion of the overall services, providing a wide range of surgical interventions and eye care solutions, which necessitates the utilization of advanced viscoelastic products to enhance surgical outcomes and patient safety.
Academic and Research Institutes contribute significantly to innovation within the market, focusing on the development and testing of new technologies that can improve ocular procedures, thus fostering advancements in Research and Development that drive market growth.
The synergy between these segments is pivotal in addressing the increasing demand for effective ophthalmic procedures, promoting advancements in medical technology, and improving patient care standards across Japan. The growing emphasis on patient safety and surgical efficacy across these segments further enhances the significance of viscoelastic devices, positioning them as essential tools in contemporary ophthalmic practices.
Japan Ophthalmic Viscoelastic Devices Market Key Players and Competitive Insights
The Japan Ophthalmic Viscoelastic Devices Market is characterized by growing competition among various key players that are persistently striving to enhance their product offerings and expand their market share.
The market landscape is influenced by advancements in technology, the increasing prevalence of eye disorders, and a rising number of cataract surgeries, which contribute to the demand for ophthalmic viscoelastic devices. The competitive dynamics in this market are shaped by both local and international manufacturers, who are focusing on research and development to innovate and improve the efficacy and safety profiles of their products.
As the market evolves, companies are increasingly forming strategic partnerships and collaborations to leverage their strengths and enhance their competitive position while addressing the needs of healthcare professionals and patients alike.
Oculentis stands out in the Japan Ophthalmic Viscoelastic Devices Market with its strong brand reputation and commitment to quality. The company focuses on providing high-performance viscoelastic solutions that cater to a variety of surgical needs during cataract procedures. Oculentis possesses a distinguished ability to blend innovation with efficiency, which has garnered trust among ophthalmic surgeons and healthcare providers in Japan.
The company ensures that its products not only meet but exceed regulatory requirements, contributing significantly to its robust market presence. With a dedicated approach to customer education and a consistent effort to gather feedback for product improvements, Oculentis has solidified its position as a prominent player in this competitive landscape, characterized by a heightened focus on surgical outcomes and patient satisfaction.Surfacematch has established a notable presence in the Japan Ophthalmic Viscoelastic Devices Market, primarily recognized for its innovative approach to viscoelastic products designed for ophthalmic surgeries.
The company provides a range of specialized devices that enhance surgical precision and patient outcomes. Surfacematch's strengths lie in its commitment to research and development, leading to the introduction of new and improved formulations that cater specifically to the needs of ophthalmic surgeons in Japan. The company emphasizes strategic collaborations and partnerships, which not only enhance its product portfolio but also widen its reach in the market.
This strategy has proven effective in positioning Surfacematch as a competitive player amidst the evolving demands of the ophthalmic device segment. Additionally, the company is actively pursuing mergers and acquisitions to bolster its capacity for innovation and expand its market footprint in Japan, aligning with the increasing trends in minimally invasive surgical techniques and personalized patient care.
Key Companies in the Japan Ophthalmic Viscoelastic Devices Market Include
- Oculentis
- Surfacematch
- Abbott Laboratories
- Bausch Health
- Santen Pharmaceutical
- Hoya Corporation
- Rhein Medical
- Carl Zeiss AG
- Moria Surgical
- Kowa Company
- Merck KGaA
- Alcon
- Johnson & Johnson
- ShinEtsu Chemical
Japan Ophthalmic Viscoelastic Devices Market Industry Developments
Recent developments in the Japan Ophthalmic Viscoelastic Devices Market highlight a dynamic landscape driven by innovation and strategic activities among key players. In August 2023, Santen Pharmaceutical announced the expansion of its product line, focusing on advanced viscoelastic formulations emphasizing technological advancements tailored to local market needs. Meanwhile, in September 2023, Alcon reported a notable increase in market share attributed to its latest surgical products targeting cataract and glaucoma procedures.
The growth of companies such as Hoya Corporation and Merck KGaA is indicative of the rising demand for ophthalmic solutions across Japan, bolstered by an aging population and increasing visual impairment issues. Notably, in July 2023, Bausch Health acquired a smaller company specializing in innovative ophthalmic technologies, which has further strengthened its position in the market.
Rhein Medical also shared plans for product enhancement and partnerships aimed at improving surgical outcomes. These activities collectively reflect the robust investment and competitive strategies of companies like Abbott Laboratories, Moria Surgical, and Johnson and Johnson, aiming to elevate market value and meet growing consumer demands in Japan's ophthalmic sector.
Japan Ophthalmic Viscoelastic Devices Market Segmentation Insights
Ophthalmic Viscoelastic Devices Market Type Outlook
- Cohesive OVDs
- Dispersive OVDs
Ophthalmic Viscoelastic Devices Market Application Outlook
- Cataract Surgery
- Glaucoma Surgery
- Corneal Transplantation
- Vitreoretinal Surgery
Ophthalmic Viscoelastic Devices Market End User Outlook
- Ophthalmic Clinics & Phaco Centers
- Hospitals
- Academic & Research Institutes
Â
Report Attribute/Metric Source: |
Details |
MARKET SIZE 2023 |
178.75(USD Million) |
MARKET SIZE 2024 |
191.88(USD Million) |
MARKET SIZE 2035 |
734.0(USD Million) |
COMPOUND ANNUAL GROWTH RATE (CAGR) |
12.972% (2025 - 2035) |
REPORT COVERAGE |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
BASE YEAR |
2024 |
MARKET FORECAST PERIOD |
2025 - 2035 |
HISTORICAL DATA |
2019 - 2024 |
MARKET FORECAST UNITS |
USD Million |
KEY COMPANIES PROFILED |
Oculentis, Surfacematch, Abbott Laboratories, Bausch Health, Santen Pharmaceutical, Hoya Corporation, Rhein Medical, Carl Zeiss AG, Moria Surgical, Kowa Company, Merck KGaA, Alcon, Johnson & Johnson, ShinEtsu Chemical |
SEGMENTS COVERED |
Type, Application, End User |
KEY MARKET OPPORTUNITIES |
Aging population driving demand, Rising prevalence of cataract surgeries, Technological advancements in device design, Growth in minimally invasive procedures, Expanding distribution channels and partnerships |
KEY MARKET DYNAMICS |
aging population, increasing eye surgeries, technological advancements, rising healthcare expenditure, growing awareness and diagnosis |
COUNTRIES COVERED |
Japan |
Frequently Asked Questions (FAQ) :
The Japan Ophthalmic Viscoelastic Devices Market is expected to be valued at approximately 191.88 million USD in 2024.
By 2035, the Japan Ophthalmic Viscoelastic Devices Market is projected to reach a value of around 734.0 million USD.
The expected compound annual growth rate (CAGR) for the Japan Ophthalmic Viscoelastic Devices Market from 2025 to 2035 is approximately 12.972%.
Cohesive OVDs are expected to have a market value of 90.0 million USD in 2024.
Dispersive OVDs are projected to reach a market value of approximately 101.88 million USD in 2024.
Key players in the market include Oculentis, Abbott Laboratories, Bausch Health, and Santen Pharmaceutical among others.
The market size for Cohesive OVDs is expected to grow to approximately 345.0 million USD by 2035.
The expected market value for Dispersive OVDs by 2035 is around 389.0 million USD.
Key growth drivers include advancements in ocular surgical procedures and increasing incidence of eye-related disorders.
The Japan Ophthalmic Viscoelastic Devices Market is one of the largest markets in Asia, driven by technological advancements and growing healthcare investments.